ANDA 76445, held by Ranbaxy Labs Ltd. Pravastatin Sodium.
As of Nov 16, 2026, ANDA 76445 (Pravastatin Sodium), held by Ranbaxy Labs Ltd, was not approved, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 30, 2003 | Original application | Tentative approval |
| Pravastatin Sodium10MG · tablet;oral | Pravastatin Sodium | Discontinued |
| Pravastatin Sodium20MG · tablet;oral | Pravastatin Sodium | Discontinued |
| Pravastatin Sodium40MG · tablet;oral | Pravastatin Sodium | Discontinued |
| Pravastatin Sodium80MG · tablet;oral | Pravastatin Sodium | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters